Supplemental Cash Flow Information (Tables)

6 Months Ended

Aug. 31, 2024

Supplemental Cash Flow Information [Abstract]

Schedule of Cash Flow, Supplemental Disclosures

The following is supplemental information relating to the Unaudited Consolidated Statements of Cash Flows:

	Six months ended August 31,
	2024			2023
Non-cash investing and financing activities:
Recording of redeemable equity	$	(63	)	$	(46	)
Investment in BioCenturion LLC		2,989			-
Cancellation of EyeLock LLC ownership put option		9,817			-
Reclassification of shareholder receivable to equity		2,578			-
Recording of excise tax attributable to treasury stock repurchases		2			-
Right of use assets obtained in exchange for operating lease obligations		556			549
Right of use assets obtained in exchange for finance lease obligations		-			575
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	610		$	648
Operating cash flows from finance leases		30			8
Finance cash flows from finance leases		204			169
Cash paid during the period:
Interest (excluding bank charges)	$	3,211		$	2,135
Income taxes (net of refunds)		2,270			910